Shares of Cronos Group (CRON) declined 13.7% to close at $3.09 on Tuesday after the cannabis company delivered mixed second-quarter results amid its business restructuring initiatives. What Does Cronos Group Do? Cronos Group is a global cannabinoid company that manufactures and sells cannabis, and hemp-derived supplements for the medical and adult-use markets in federally legal jurisdictions, including the U.S., Canada, and Germany. Its international brand portfolio includes Spinach, Peace Naturals, Lord Jones, Happy Dance And Peace+. A Snapshot of CRON’s Q2 Performance The company reported an adjusted loss of $0.05 per share, which was just a cent less than the street’s estimated loss of $0.06.
https://www.tipranks.com/news/why-did-cronos-stock-decline-13-7-on-tuesday?utm_source=advfn.com&utm_medium=referral
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Cronos Charts.
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Cronos Charts.